Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment

被引:68
作者
Albai, Oana [1 ]
Frandes, Mirela [2 ]
Timar, Romulus [1 ]
Roman, Deiana [3 ]
Timar, Bogdan [2 ]
机构
[1] Victor Babes Univ Med & Pharm, Dept Internal Med 2, Timisoara, Romania
[2] Victor Babes Univ Med & Pharm, Dept Funct Sci, 2 Eftimie Murgu, Timisoara 300041, Romania
[3] Municipal Clin Emergency Hosp, Timisoara, Romania
关键词
diabetes mellitus; metabolic syndrome; insulin resistance; cognitive impairment; dementia; GLYCATION END-PRODUCTS; BRAIN ATROPHY; GLOBAL PREVALENCE; DECLINE; DYSFUNCTION; PROJECTIONS; INSULIN; DISEASE;
D O I
10.2147/NDT.S189905
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Background: Dementia and cognitive dysfunction have many causes. There is strong evidence that diabetes mellitus (DM) increases the risk of cognitive impairment and dementia. Optimal glycemic control, identification of diabetic risk factors, and prophylactic approach are essential in the prevention of cognitive complications. Aims: The main purpose of this study was to establish the cognitive impairment in DM patients, cared for in the Diabetes Center from Timisoara. Also, we investigated the prevalence of dementia in our group as well as the risk factors involved in the progression of mild cognitive impairment (MCI) to dementia. Patients and methods: We considered a sample of 207 type 2 DM (T2DM) patients, aged between 33 and 81 years, mean 57.49 (+/- 11.37) years. We established the diagnosis of dementia based on the Mini-Mental State Examination (MMSE) test, as well as on the psychological testing, psychiatric and neurological investigations, and imaging tests (computerized tomography and MRI). Results: A percentage of 42.03% of patients presented MCI, mean age 63 (57.00-71.00) years, being older than patients without MCI, mean age 52.00 (45.00-61.00) years, P<0.001. We observed that diabetes duration was a significant risk factor for developing dementia. Also, patients with MCI presented higher values of body fat than patients without MCI. Moreover, we found that glucose levels, low-density lipoprotein cholesterol levels, the presence of stroke events, and the presence of cardiovascular disease were significant risk factors for MCI conversion to dementia. Conclusion: Patients with T2DM at early to severe stages of MCI are more likely to develop dementia and should be regularly evaluated for their cognitive status. Regular administrations of the MMSE test can be done to detect early stages of MCI development. Also, to reduce the progression of cognitive impairment to dementia, it is worthwhile to give greater importance to glycemic control and overall DM management.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 42 条
[1]
Hypertriglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus [J].
Albai, Oana ;
Roman, Deiana ;
Frandes, Mirela .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 :515-522
[2]
Assessment of cognitive status in patients with type 2 diabetes through the mini-mental status examination: a cross-sectional study [J].
Alencar, Renata C. ;
Cobas, Roberta A. ;
Gomes, Marilia B. .
DIABETOLOGY & METABOLIC SYNDROME, 2010, 2
[3]
Diabetes and function in different cognitive systems in older individuals without dementia [J].
Arvanitakis, Z ;
Wilson, RS ;
Li, Y ;
Aggarwal, NT ;
Bennett, DA .
DIABETES CARE, 2006, 29 (03) :560-565
[4]
Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions [J].
Biessels, Geert Jan ;
Strachan, Mark W. J. ;
Visseren, Frank L. J. ;
Kappelle, L. Jaap ;
Whitmer, Rachel A. .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (03) :246-255
[5]
Risk of dementia in diabetes mellitus: a systematic review [J].
Biessels, GJ ;
Staekenborg, S ;
Brunner, E ;
Brayne, C ;
Scheltens, P .
LANCET NEUROLOGY, 2006, 5 (01) :64-74
[6]
Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study [J].
Bruce, DG ;
Casey, GP ;
Grange, V ;
Clarnette, RC ;
Almeida, OP ;
Foster, JK ;
Ives, FJ ;
Davis, TME .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (01) :59-67
[7]
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes [J].
Candido, R ;
Forbes, JM ;
Thomas, MC ;
Thallas, V ;
Dean, RG ;
Burns, WC ;
Tikellis, C ;
Ritchie, RH ;
Twigg, SM ;
Cooper, ME ;
Burrell, LM .
CIRCULATION RESEARCH, 2003, 92 (07) :785-792
[8]
Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment [J].
Ciudin, Andreea ;
Espinosa, Ana ;
Simo-Servat, Olga ;
Ruiz, Agustin ;
Alegret, Montserrat ;
Hernandez, Cristina ;
Boada, Merce ;
Simo, Rafael .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (08) :1272-1274
[9]
Screening for dementia in an Irish community sample using MMSE: a comparison of norm-adjusted versus fixed cut-points [J].
Cullen, B ;
Fahy, S ;
Cunningham, CJ ;
Coen, RF ;
Bruce, I ;
Greene, E ;
Coakley, D ;
Walsh, JB ;
Lawlor, BA .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 20 (04) :371-376
[10]
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment [J].
Danaei, Goodarz ;
Lu, Yuan ;
Singh, Gitanjali M. ;
Carnahan, Emily ;
Stevens, Gretchen A. ;
Cowan, Melanie J. ;
Farzadfar, Farshad ;
Lin, John K. ;
Finucane, Mariel M. ;
Rao, Mayuree ;
Khang, Young-Ho ;
Riley, Leanne M. ;
Mozaff, Dariush ;
Lim, Stephen S. ;
Ezzati, Majid ;
Aamodt, Geir ;
Abdeen, Ziad ;
Abdella, Nabila A. ;
Abdul Rahim, Hanan F. ;
Addo, Juliet ;
Aekplakorn, Wichai ;
Afifi, Mustafa M. ;
Agabiti-Rosei, Enrico ;
Salinas, Carlos A. Aguilar ;
Agyemang, Charles ;
Ali, Mohammed K. ;
Ali, Mohamed M. ;
Al-Nsour, Mohannad ;
Al-Nuaim, Abdul R. ;
Ambady, Ramachandran ;
Di Angelantonio, Emanuele ;
Aro, Pertti ;
Azizi, Fereidoun ;
Babu, Bontha V. ;
Bahalim, Adil N. ;
Barbagallo, Carlo M. ;
Barbieri, Marco A. ;
Barcelo, Alberto ;
Barreto, Sandhi M. ;
Barros, Henrique ;
Bautista, Leonelo E. ;
Benetos, Athanase ;
Bjerregaard, Peter ;
Bjoerkelund, Cecilia ;
Bo, Simona ;
Bobak, Martin ;
Bonora, Enzo ;
Botana, Manuel A. ;
Bovet, Pascal ;
Breckenkamp, Juergen .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (08) :634-647